Method for detecting hepatitis B virus DNA and G1896A mutation thereof and kit
A hepatitis B virus, G1896A technology, applied in biochemical equipment and methods, microbial determination/inspection, etc., can solve problems such as prolonging the running time of PCR programs, achieve beautiful and stable amplification curves, reduce detection costs, and facilitate The effect of promoting the application
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0098] Example 1: Extraction of HBV DNA from clinical blood samples
[0099] Take 50μl of serum from clinical blood samples into a high-pressure 1.5ml centrifuge tube, add 25μl of extract A (40% PEG-8000), shake and mix for 5s, and centrifuge at 12,500g for 5min; discard the supernatant, add 25μl to extract Solution B (0.25M NaOH), shake for 15s to dissolve the precipitate as much as possible, lyse at 96°C for 10min; add 25μl of extract C (0.4M Tris-HCl buffer, pH6.4), mix well, 96°C for 10min; centrifuge at 12,500g After 15 min, 5 μl of supernatant was taken for PCR amplification.
Embodiment 2
[0100] Example 2: PCR Amplification of Target Nucleic Acids
[0101] Add a single dose of PCR reaction mixture to a PCR reaction tube, then add 0.2 μl of enzyme mixture, and finally add 5 μl of template (template to be tested or negative and positive control), mix well and then centrifuge slightly (about 5 μl). second). Then put the reaction tube into a fluorescent PCR machine (a PCR machine that can detect FAM and HEX), and amplify according to the following conditions: 50°C for 120 seconds (1 cycle) → 95°C for 180 seconds (1 cycle) → 95°C for 10 seconds seconds, 56°C for 30 seconds (40 cycles), where 56°C is the temperature at which fluorescence is detected.
[0102] The PCR amplification system used includes: 2.5μl 10x PCR buffer (850mM KCl, 400mM Tris-Cl, pH8.9, 50% v / v glycerol), 0.2μl enzyme mixture, 0.2μl dUTPs (containing dATP, dUTP, dGTP, dCTP each 25mM), two forward and reverse primers (SEQ ID NO: 1 and SEQ ID NO: 2, 100 μM) each 0.1 μl, wild type and mutant molecu...
Embodiment 3
[0103] Example 3: Hepatitis B virus DNA G 1896 Sensitive and specific detection of A mutation
[0104] with G 1896 A plasmid of mutated hepatitis B virus DNA fragment (1.0 × 10 6 copies / ml-1.0×10 2 copies / ml) as a template, use the reagent of the present invention to treat hepatitis B disease
[0105] Toxic DNA G 1896 The sensitivity of A mutation is detected. For the detection results, see figure 1 . from figure 1 It can be seen from the results that the method and kit of the present invention can at least detect that the template concentration is only 1.0×10 2 copies / ml G 1896 A mutated hepatitis B virus DNA. In other words, the sensitivity of the present invention can fully meet the clinical requirements.
[0106] Then 16 wild-type hepatitis B virus DNA (about 1.0 × 10) with no mutation at site 1896 6 copies / ml) is a template, and the specificity of the mutant probe marked by FAM is detected using the reagent of the present invention, and the detection results re...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More - R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com
